2016
DOI: 10.1080/14779072.2016.1207527
|View full text |Cite
|
Sign up to set email alerts
|

Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis

Abstract: This review examines some of the most common associations between therapies of cardiovascular disease and the endothelium, and summarizes the direction of research that may set the stage for one or more interventions targeted to repair damaged and/or dysfunctional endothelium. Expert commentary: Routine treatment of cardiovascular disease has frequently been shown to have a positive effect on the vascular endothelium. The big question - whether the impact is due to a direct pharmacological effect or whether th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
53
0
15

Year Published

2017
2017
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 74 publications
(69 citation statements)
references
References 136 publications
1
53
0
15
Order By: Relevance
“…Atherosclerosis (AS) is a progressive condition involving accumulation of lipids and fibrous elements in the large arteries, which is a key trigger for CVD [3]. Endothelial cell dysfunction is an important characteristic of AS [4, 5]. Both oxidative stress and mitochondrial dysfunction are responsible for the development of endothelial dysfunction [6, 7].…”
Section: Introductionmentioning
confidence: 99%
“…Atherosclerosis (AS) is a progressive condition involving accumulation of lipids and fibrous elements in the large arteries, which is a key trigger for CVD [3]. Endothelial cell dysfunction is an important characteristic of AS [4, 5]. Both oxidative stress and mitochondrial dysfunction are responsible for the development of endothelial dysfunction [6, 7].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, it is necessary to focus on the potential targets of endothelial dysfunction, which in turn would provide novel prevention and treatment strategies [33]. …”
Section: Discussionmentioning
confidence: 99%
“…Increased metabolic risk in the offspring is often brought about by maternal gestational diabetes (GDM) (4) and apart from the well-documented short-term adverse obstetric and perinatal complications associated with GDM (5), long-term future metabolic health and neurodevelopmental implications for the offspring have been described (6). The intrauterine exposure to maternal diabetes has also been linked to higher cardiovascular stress responses in the offspring (7) and cardiovascular disease can become apparent in form of endothelial dysfunction (ED) (8,9). Elevation of markers have been linked to inflammation and ED in ADVANCE ARTICLE: Endocrinology 2 umbilical cord blood (10) and ED early in life may accelerate the onset of cardiovascular disease (11), which is supported by the evidence that offspring of mothers with GDM have an increased cardiovascular disease risk (12,13).…”
mentioning
confidence: 99%